Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COBOVIT-Q10 is a multi-ingredient nutritional supplement and antioxidant formulation developed and marketed by ZRS Pharmaceuticals India Pvt. Ltd. The product is a combination therapy typically centered around Coenzyme Q10 (Ubidecarenone) and various vitamins (often including B-complex vitamins like Methylcobalamin, suggested by the 'COBOVIT' prefix). Coenzyme Q10 is a critical component of the mitochondrial electron transport chain, where it facilitates the production of adenosine triphosphate (ATP) and serves as a potent lipid-soluble antioxidant. COBOVIT-Q10 is generally indicated for the management of nutritional deficiencies, support of cardiovascular health, and as an adjunct treatment for conditions associated with oxidative stress or mitochondrial dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on COBOVIT-Q10.